Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
7.03
-0.42 (-5.64%)
Apr 29, 2026, 1:15 PM EDT - Market open
Solid Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 59.9 | 80.24 | 74.02 | 155.38 | 119.14 | Upgrade
|
| Short-Term Investments | 127.95 | 68.69 | 49.63 | 58.34 | 88.64 | Upgrade
|
| Cash & Short-Term Investments | 187.85 | 148.92 | 123.64 | 213.72 | 207.78 | Upgrade
|
| Cash Growth | 26.14% | 20.45% | -42.15% | 2.86% | 34.27% | Upgrade
|
| Receivables | - | - | - | - | 0.11 | Upgrade
|
| Prepaid Expenses | 2.42 | 1.65 | 2.11 | 3 | 8.71 | Upgrade
|
| Restricted Cash | 1.22 | - | - | - | - | Upgrade
|
| Other Current Assets | 13.97 | 6.73 | 3.98 | 2.91 | 6.02 | Upgrade
|
| Total Current Assets | 205.46 | 157.3 | 129.73 | 219.64 | 222.61 | Upgrade
|
| Property, Plant & Equipment | 26.09 | 29.04 | 33.16 | 38.61 | 7.6 | Upgrade
|
| Other Long-Term Assets | 0.99 | 2.32 | 2.04 | 2.01 | 2.16 | Upgrade
|
| Total Assets | 232.54 | 188.66 | 164.94 | 260.25 | 232.38 | Upgrade
|
| Accounts Payable | 3.22 | 4.24 | 2.03 | 3.24 | 4.46 | Upgrade
|
| Accrued Expenses | 18.95 | 19.85 | 10.16 | 16.69 | 9.53 | Upgrade
|
| Current Portion of Leases | 2.1 | 3.02 | 2.32 | 2.57 | 1.5 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 8.08 | Upgrade
|
| Other Current Liabilities | 9.2 | 3.15 | - | 0.01 | 0.04 | Upgrade
|
| Total Current Liabilities | 33.47 | 30.26 | 14.52 | 22.51 | 23.6 | Upgrade
|
| Long-Term Leases | 19.06 | 21.16 | 23.94 | 25.98 | 0.57 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 0.1 | - | Upgrade
|
| Total Liabilities | 52.53 | 51.42 | 38.46 | 48.59 | 24.17 | Upgrade
|
| Common Stock | 0.08 | 0.04 | 0.02 | 0.02 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 1,138 | 920.61 | 785.2 | 774.45 | 685.01 | Upgrade
|
| Retained Earnings | -957.78 | -783.45 | -658.75 | -562.74 | -476.76 | Upgrade
|
| Comprehensive Income & Other | 0.05 | 0.05 | 0.02 | -0.07 | -0.05 | Upgrade
|
| Total Common Equity | 180.01 | 137.25 | 126.48 | 211.67 | 208.21 | Upgrade
|
| Shareholders' Equity | 180.01 | 137.25 | 126.48 | 211.67 | 208.21 | Upgrade
|
| Total Liabilities & Equity | 232.54 | 188.66 | 164.94 | 260.25 | 232.38 | Upgrade
|
| Total Debt | 21.16 | 24.18 | 26.27 | 28.55 | 2.06 | Upgrade
|
| Net Cash (Debt) | 166.69 | 124.74 | 97.38 | 185.18 | 205.72 | Upgrade
|
| Net Cash Growth | 33.63% | 28.11% | -47.41% | -9.98% | 37.52% | Upgrade
|
| Net Cash Per Share | 1.90 | 3.06 | 4.90 | 21.75 | 28.90 | Upgrade
|
| Filing Date Shares Outstanding | 98.39 | 77.49 | 37.76 | 19.57 | 7.36 | Upgrade
|
| Total Common Shares Outstanding | 78.97 | 40.47 | 20.39 | 19.56 | 7.36 | Upgrade
|
| Working Capital | 171.98 | 127.05 | 115.22 | 197.13 | 199.01 | Upgrade
|
| Book Value Per Share | 2.28 | 3.39 | 6.20 | 10.82 | 28.30 | Upgrade
|
| Tangible Book Value | 180.01 | 137.25 | 126.48 | 211.67 | 208.21 | Upgrade
|
| Tangible Book Value Per Share | 2.28 | 3.39 | 6.20 | 10.82 | 28.30 | Upgrade
|
| Machinery | 17.41 | 16.1 | 17.92 | 17.96 | 11.37 | Upgrade
|
| Construction In Progress | 0.4 | 0.88 | 0.41 | 1.72 | 1.49 | Upgrade
|
| Leasehold Improvements | 0.48 | 0.47 | 0.48 | 0.38 | 4.71 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.